Skip to main content

Table 2 Univariate and multivariate associations with time from last positive HIV test and initiation of ART

From: Evidence of improving antiretroviral therapy treatment delays: an analysis of eight years of programmatic outcomes in Blantyre, Malawi

Variable GMR± 95% CI* Adjusted GMR± 95% CI* P
Sex      
  Men 1   1   0.007
  Women 1.13 1.06-1.21 1.12 1.03-1.22  
Age group      
  0-5 years 0.87 0.75-0.99 1.02 0.84-1.24 0.526
  5-15 years 1.16 0.99-1.37 1.14 0.93-1.39  
  15-25 years 1.00 0.89-1.23 0.93 0.81-1.08  
  25-35 years 1   1   
  35-45 years 1.00 0.92-1.08 0.96 0.87-1.06  
  ≥ 45 years 1.00 0.90-1.10 0.96 0.84-1.09  
Site of HIV test      
  QECH 1   1   
  Facility other than QECH 1.65 1.54-1.77 1.61 1.47-1.77 <0.001
  Unknown 1.82 1.64-2.02 1.93 1.66-2.24  
WHO stage at registration      
  Stage 1 or 2 1     
  Stage 3 or 4 1.01 0.95-1.08    
CD4 count (cells/μl)      
  ≥ 350 1   1   <0.001
  250 – 350 0.87 0.70-1.11 0.96 0.75-1.20  
  50 – 250 0.76 0.61-0.95 0.77 0.62-0.98  
  <50 0.50 0.40-0.63 0.53 0.42-0.68  
Year of ART initiation      
  2004 0.92 0.75-1.14 0.79 0.52-1.21 0.004
  2005 1   1   
  2006 0.72 0.60-0.87 0.75 0.48-1.16  
  2007 0.64 0.55-0.76 0.71 0.50-1.03  
  2008 0.68 0.59-0.80 0.72 0.51-1.02  
  2009 0.69 0.59-0.80 0.69 0.49-0.99  
  2010 0.75 0.64-0.88 0.85 0.60-1.21  
  2011 0.54 0.47-0.63 0.84 0.59-1.21  
Number of ART initiators per year (continuous) 1.00 1.00-1.00    
  1. ±Bootstrapped estimates of geometric mean ratios, adjusted for sex, age group, site of HIV test, CD4 count strata and year of ART initiation.
  2. *Bias corrected accelerated 95% confidence intervals.
  3. GMR Geometric mean ratio, CI confidence interval, QECH Queen Elizabeth Central Hospital.